Multimodal Weight Management Program for Older Adults
Official title: Interdisciplinary Approaches to Managing Excess Weight and Promoting Health in Older Adults: a Multimodal Intervention
Run by Universidade Cesumar (UNICESUMAR) · NCT07820774 · Data updated 2026-11-12
A 16-week program tests whether combining resistance training, group cognitive behavioral therapy, and a high-protein diet helps adults aged 60 and older with overweight or obesity.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 54 (estimated) |
| Sponsor | Universidade Cesumar (UNICESUMAR) Academic / other |
| Locations | 1 site (Maringá) |
| Status | Recruiting |
| Started | September 14, 2026 |
| Main results expected | February 2, 2027 |
| Study ends | August 5, 2027 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07820774 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 60 years or older with excess adiposity who can safely participate in supervised resistance training and have not engaged in structured resistance training recently.
✕Probably not a fit
Individuals with contraindications to exercise, unstable cardiovascular disease, recent major cardiovascular events, uncontrolled hypertension, or other factors that prevent safe participation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates a 16-week plan that combines resistance training, nutritional guidance for a high-protein diet, and group cognitive behavioral therapy to improve body composition, muscle strength, metabolic health, and quality of life in older adults with excess weight. Participants aged 60+ with low activity levels are randomly assigned to three groups to compare the effects of the different components, including a resistance-training-only group. Outcomes include body composition, muscle strength and function, vascular and metabolic health, cognitive function, psychological well-being, and autonomy. The trial is conducted at UniCesumar in Maringá, Brazil, and requires medical clearance for supervised exercise.
Why it matters
Potential benefit: If successful, the program could help older adults lose fat, gain muscle, and improve overall health and daily functioning.
How similar studies have gone: Previous research suggests combined exercise, nutrition, and behavioral strategies can improve health in older adults, with ongoing work to optimize this multimodal approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 60 years; * Presence of excess adiposity/overweight or obesity, according to protocol criteria; * Medical clearance to perform supervised physical exercises and the tests; * No regular participation in structured resistance training over the past 5 months. Exclusion Criteria: * Contraindication to resistance training or physical testing; * Unstable or uncontrolled cardiovascular disease; * Recent (\< 6 months) coronary or cerebrovascular event; * Uncontrolled arterial hypertension; * Untreated secondary/endocrine causes of obesity; * Use of medications that significantly alter body mass or composition; * Current use of anti-obesity medication, including GLP-1 agonists; * History of bariatric surgery or scheduled procedure; * Active weight loss process or weight fluctuation \> 5% in the last 6 months.
Where it's running
-
UniCesumar - Centro Universitário Cesumar, Maringá, Paraná 87050-900
Maringá, Brazil Recruiting
Study contacts
- Principal investigator: Vitor S Painelli, Dr. — UniCesumar - Centro Universitário Cesumar
- Study coordinator: Mariana S Januário, Bachelor's degree
- Email: marianapsicologaesporte@gmail.com
- Phone: +5544991042906
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How incretin treatments affect muscle mass and function in people with overweight or obesity
This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.
-
Dose find for remimazolam plus alfentanil for gastroscopy in obese adults
This trial tests what dose of remimazolam besylate with alfentanil best sedates obese adults during gastroscopy.
-
Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults
This study compares how much weight adults lose over two years when starting GLP-1 medicines versus adults who had sleeve gastrectomy at the same center.
-
Gut barrier and inflammation after fast-food overfeeding in adults
This study tests whether 14 days of fast-food overfeeding can alter gut barrier function and trigger inflammation in adults who are generally healthy.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
GLP-1 weight‑loss medicine: finding who will benefit most
This study tests whether a GLP-1 drug called semaglutide helps with weight loss by changing eating behavior, to see which people it helps the most.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.